[KongchangAI]
Unverified50% confidenceCautionExact time

The disease labels used in the study are proxy labels, not clinical gold-standard grading, and independent reference caliber measurements are lacking, so the 96.7% accuracy only demonstrates that the pipeline is feasible in exploratory settings, not clinically usable screening performance.

1
Sources
50%
Confidence
Medium-term (~90 days)
Relevance
11/11/2026
First Seen
Valid until: 2/9/2027

Sources

Related Entities

Related Claims

Cite This Claim

Stable URI
https://kongchang.com/claim/1158143
API
curl https://kongchang.com/api/v1/knowledge/claims/1158143
MCP
get_claim(id=1158143)